With use of GLP-1 medications surging, there are some important, though often overlooked, health issues that users should be ...

Meanwhile, the U.K.'s Medicines and Healthcare Products Regulatory Agency updated its warnings on GLP-1 and dual GLP-1/GIP ...

GI side effects. These are common with these medications and can include nausea, diarrhea, abdominal pain, and vomiting. “Symptoms are often tolerable in younger patients; they can precipitate serious ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the ...

"She was just laying there lifeless,” Melissa Melinder, whose daughter thought GLP-1s helped with stomachaches, said ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked.

Researchers at Steno Diabetes Center Copenhagen reported that starting a GLP-1 receptor agonist (GLP-1RA) coincided with slightly healthier supermarket purchases. Grocery purchases from GLP-1RA users ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

Poison control calls involving GLP-1 medications like semaglutide and tirzepatide have dramatically risen in recent years.

Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...